Acetylsalicylic Acid, Aging and Coronary Artery Disease Are Associated with ABCA1 DNA Methylation in Men

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2014 Aug 6

PMID 25093045

Citations 31

Authors

Simon-Pierre Guay

Cecilia Legare

Andree-Anne Houde

Patrick Mathieu

Yohan Bosse

Luigi Bouchard

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have suggested that DNA methylation contributes to coronary artery disease (CAD) risk variability. DNA hypermethylation at the ATP-binding cassette transporter A1 (ABCA1) gene, an important modulator of high-density lipoprotein cholesterol and reverse cholesterol transport, has been previously associated with plasma lipid levels, aging and CAD, but the association with CAD has yet to be replicated.

Results: ABCA1 DNA methylation levels were measured in leucocytes of 88 men using bis-pyrosequencing. We first showed that DNA methylation at the ABCA1 gene promoter locus is associated with aging and CAD occurrence in men (P < 0.05). The latter association is stronger among older men with CAD (≥61 years old; n = 19), who showed at least 4.7% higher ABCA1 DNA methylation levels as compared to younger men with CAD (<61 years old; n = 19) or men without CAD (n = 50; P < 0.001). Higher ABCA1 DNA methylation levels in older men were also associated with higher total cholesterol (r = 0.34, P = 0.03), low-density lipoprotein cholesterol (r = 0.32, P = 0.04) and triglyceride levels (r = 0.26, P = 0.09). Furthermore, we showed that acetylsalicylic acid therapy is associated with 3.6% lower ABCA1 DNA methylation levels (P = 0.006), independent of aging and CAD status of patients.

Conclusions: This study provides new evidence that the ABCA1 epigenetic profile is associated with CAD and aging, and highlights that epigenetic modifications might be a significant molecular mechanism involved in the pathophysiological processes associated with CAD. Acetylsalicylic acid treatment for CAD prevention might involve epigenetic mechanisms.

Citing Articles

Epigenetic regulation in coronary artery disease: from mechanisms to emerging therapies.

Gao R, Liu M, Yang H, Shen Y, Xia N Front Mol Biosci. 2025; 12:1548355.

PMID: 39959304 PMC: 11825346. DOI: 10.3389/fmolb.2025.1548355.

A novel approach for target deconvolution from phenotype-based screening using knowledge graph.

Wang X, Zhang M, Xu J, Li X, Xiong J, Cao H Sci Rep. 2025; 15(1):2414.

PMID: 39827292 PMC: 11742725. DOI: 10.1038/s41598-025-86166-w.

Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases.

Komal S, Gao Y, Wang Z, Yu Q, Wang P, Zhang L Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458994 PMC: 11510975. DOI: 10.3390/ph17101353.

Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.

Bontempo P, Capasso L, De Masi L, Nebbioso A, Rigano D Nutrients. 2024; 16(15).

PMID: 39125279 PMC: 11314203. DOI: 10.3390/nu16152399.

Therapeutic Strategies for Angiogenesis Based on Endothelial Cell Epigenetics.

Cai Y, Li L, Shao C, Chen Y, Wang Z J Cardiovasc Transl Res. 2024; 17(4):816-827.

PMID: 38294628 DOI: 10.1007/s12265-024-10485-y.

References

Guay S, Brisson D, Lamarche B, Gaudet D, Bouchard L . Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics. 2014; 9(5):718-29. PMC: 4063831. DOI: 10.4161/epi.27981. View

Guay S, Voisin G, Brisson D, Munger J, Lamarche B, Gaudet D . Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics. 2012; 4(6):623-39. DOI: 10.2217/epi.12.62. View

Nordestgaard B, Chapman M, Humphries S, Ginsberg H, Masana L, Descamps O . Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45):3478-90a. PMC: 3844152. DOI: 10.1093/eurheartj/eht273. View

Xu L, Zheng D, Wang L, Jiang D, Liu H, Xu L . GCK gene-body hypomethylation is associated with the risk of coronary heart disease. Biomed Res Int. 2014; 2014:151723. PMC: 3947703. DOI: 10.1155/2014/151723. View

Tobi E, Lumey L, Talens R, Kremer D, Putter H, Stein A . DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009; 18(21):4046-53. PMC: 2758137. DOI: 10.1093/hmg/ddp353. View

Ranga G, Kalra O, Tandon H, Gambhir J, Mehrotra G . Effect of aspirin on lipoprotein(a) in patients with ischemic stroke. J Stroke Cerebrovasc Dis. 2007; 16(5):220-4. DOI: 10.1016/j.jstrokecerebrovasdis.2007.05.003. View

Jacobsen S, Gillberg L, Bork-Jensen J, Ribel-Madsen R, Lara E, Calvanese V . Young men with low birthweight exhibit decreased plasticity of genome-wide muscle DNA methylation by high-fat overfeeding. Diabetologia. 2014; 57(6):1154-8. DOI: 10.1007/s00125-014-3198-8. View

Francis G, Knopp R, Oram J . Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest. 1995; 96(1):78-87. PMC: 185175. DOI: 10.1172/JCI118082. View

Bird A . DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16(1):6-21. DOI: 10.1101/gad.947102. View

10.

Kodach L, Jacobs R, Voorneveld P, Wildenberg M, Verspaget H, van Wezel T . Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut. 2011; 60(11):1544-53. DOI: 10.1136/gut.2011.237495. View

11.

Cheong H, Park S, Kim M, Park J, Lee J, Byun J . Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy. 2010; 66(5):637-44. DOI: 10.1111/j.1398-9995.2010.02514.x. View

12.

Vinals M, Bermudez I, Llaverias G, Alegret M, Sanchez R, Vazquez-Carrera M . Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. Cardiovasc Res. 2005; 66(1):141-9. DOI: 10.1016/j.cardiores.2004.12.024. View

13.

Sethi A, Parmar H, Kumar A . The effect of aspirin on atherogenic diet-induced diabetes mellitus. Basic Clin Pharmacol Toxicol. 2011; 108(6):371-7. DOI: 10.1111/j.1742-7843.2010.00663.x. View

14.

Joyce C, Freeman L, Brewer Jr H, Santamarina-Fojo S . Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol. 2003; 23(6):965-71. DOI: 10.1161/01.ATV.0000055194.85073.FF. View

15.

Civeira F, Lanzberg A, Isaia P, Berg J, Janus E, Smith Jr M . Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 1994; 107(1):85-98. DOI: 10.1016/0021-9150(94)90144-9. View

16.

Jiang D, Zheng D, Wang L, Huang Y, Liu H, Xu L . Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One. 2013; 8(3):e59752. PMC: 3610900. DOI: 10.1371/journal.pone.0059752. View

17.

Talens R, Christensen K, Putter H, Willemsen G, Christiansen L, Kremer D . Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell. 2012; 11(4):694-703. PMC: 3399918. DOI: 10.1111/j.1474-9726.2012.00835.x. View

18.

Wang J, Burnett J, Near S, Young K, Zinman B, Hanley A . Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol. 2000; 20(8):1983-9. DOI: 10.1161/01.atv.20.8.1983. View

19.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M . Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci. 2009; 55(1):54-9. DOI: 10.1007/s10620-008-0701-4. View

20.

Chang P, Chen Y, Chang F, Lu J, Huang W, Yang T . Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovasc Res. 2013; 99(1):137-45. DOI: 10.1093/cvr/cvt062. View